But MPX NJ’s “Be” hasn’t opened its doors off the Boardwalk as planned.
The company’s relationship with its investor iAnthus has soured, and some former leaders at MPX NJ are out. The two companies have argued over which has rights to build out the property and are wrestling now for control over the license. It’s one of only 12 the state has awarded.
As the property languishes, New Jersey’s 113,000 medical marijuana patients struggle to find affordable and accessible cannabis. Many have reported long lines and commutes only to encounter product shortages.
Former MPX owner and iAnthus employee Julie Winter alleges iAnthus pushed out MPX’s diverse leadership and also misled state officials about its progress in opening, according to correspondence sent to the state Department of Health and the chair of Cannabis Regulatory Commission obtained by NJ Advance Media.
MPX NJ won a coveted vertically integrated license — which allows it to grow, process and dispense marijuana — in 2018. But it is one of just two companies from that licensing round that has not opened a dispensary yet.
By Amanda Hoover | NJ Advance Media For NJ.com